Soligenix Inc (SNGX) Stock Analysis

Soligenix Inc (SNGX) is a publicly traded company in the HEALTHCARE sector. It trades at $0.75, carries a market capitalization of $12.23M. This page summarizes the public market data, fundamentals, and frequently asked questions for SNGX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.75
• Market Cap: $12.23M
• EPS: $-1.45
• 52-Week High: $6.23
• 52-Week Low: $0.28

Market Sentiment

Soligenix Inc currently has a Bullish sentiment score of 0.16.

About Soligenix Inc

Soligenix Inc. is a clinical-stage biopharmaceutical company based in Princeton, New Jersey, dedicated to the development and commercialization of innovative treatments for rare diseases, particularly in oncology and inflammation. The company boasts a diverse pipeline of therapeutic candidates that address critical unmet medical needs, highlighting its commitment to improving patient outcomes. With a strategic focus on rare diseases, Soligenix is well-positioned in a niche market, presenting ...

GNG Research Analysis

GNG Research scores Soligenix Inc (SNGX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SNGX.

Frequently Asked Questions

Does SNGX pay dividends?

Soligenix Inc (SNGX) does not currently pay a regular dividend.

What is SNGX's market cap?

Soligenix Inc (SNGX) has a market capitalization of $12.23M with a current stock price of $0.75.